\-\ Texto\\:\\ \ \(0\)\
\-\ wdwnwm\\ in\\ nad\\.\\ he\\ had\\ exquisite\\ tenderness\\ to\\ palpation\\ in\\ right\\ lower\\ quadrant\\.\\ laboratory\\ analyis\\ was\\ unremarkable\\.\ \(0\)\
\-\ endovascular\\ placement\\ of\\ covered\\ stent\\ to\\ exclude\\ psa\\.\ \(0\)\
\-\ ct\\ revealed\\ an\\ end\\-to\\-side\\ aortic\\-right\\ external\\ iliac\\ bypass\\ graft\\,\\ with\\ an\\ aneurysm\\ at\\ the\\ distal\\ anastomosis\\.\\ there\\ was\\ also\\ a\\ near\\ obstructing\\ carcinoma\\ in\\ the\\ ascending\\ colon\\,\\ which\\ brought\\ the\\ patient\\ to\\ medical\\ attention\\.\\ \ \(0\)\
\-\ although\\ there\\ was\\ no\\ evidence\\ of\\ aneurysm\\ rupture\\,\\ the\\ patient\\â\\€\\™s\\ worsening\\ symptoms\\ prompted\\ angiography\\ and\\ placement\\ of\\ a\\ 10\\ mm\\ x\\ 4\\ cm\\ stent\\-graft\\ \\(bard\\ fluency\\,\\ tempe\\,\\ az\\.\\)\\ \\ completion\\ arteriogram\\ demonstrates\\ excellent\\ exclusion\\ of\\ the\\ aneurysm\\ sac\\ with\\ no\\ evidence\\ of\\ endoleak\\.\\ \\ there\\ were\\ no\\ complications\\ from\\ the\\ procedure\\.\\ the\\ patient\\ underwent\\ extended\\ right\\ colectomy\\ 3\\ days\\ later\\.\ \(0\)\
\-\ anastamotic\\ pseudoaneurysm\ \(0\)\
\-\ pseudoaneurysm\\ \\(psa\\)\ \(0\)\
\-\ aneurysm\ \(644\)\
\-\ inflammatory\\ aneurysm\ \(4\)\
\-\ case\\ report\\:\\ the\\ patient\\ is\\ a\\ 69\\ year\\-old\\ male\\ 20\\ years\\ s\\/p\\ aorta\\-right\\ iliac\\ and\\ left\\ femoral\\ bypass\\ graft\\ for\\ aortic\\ occlusive\\ disease\\.\\ he\\ presented\\ with\\ 3\\ days\\ of\\ intermittent\\ but\\ escalating\\ right\\ lower\\ quadrant\\ pain\\.\ \(0\)\
\-\ anastomotic\\ pseudoaneurysm\ \(0\)\
\-\ topic\\ 7404\\ \\-\\ created\\:\\ 2006\\-10\\-24\\ 19\\:24\\:49\\-04\\ \\-\\ modified\\:\\ 2006\\-10\\-29\\ 15\\:57\\:51\\.572611\\-05\\ \\ \ \(0\)\
\-\ acr\\ index\\:\\ 9\\.4\ \(0\)\
\-\ \\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\ \(1\)\
\-\ \\ discussion\\:\\ while\\ endovascular\\ stent\\-grafting\\ has\\ become\\ an\\ established\\ treatment\\ for\\ atherosclerotic\\ aneurysm\\,\\ other\\ applications\\ are\\ constantly\\ evolving\\.\\ the\\ vascular\\ surgery\\ literature\\ has\\ come\\ to\\ advocate\\ endovascular\\ stent\\-grafts\\ as\\ treatment\\ for\\ the\\ so\\-called\\ para\\-anastomotic\\ aneurysm\\ \\(paa\\)\\.\\ these\\ commonly\\ occur\\ at\\ the\\ distal\\ anastomosis\\ of\\ a\\ bifurcated\\ aorto\\-iliac\\ bypass\\ graft\\.1\\ at\\ 15\\ year\\ followup\\,\\ the\\ cumulative\\ incidence\\ of\\ iliac\\ artery\\ paas\\ is\\ \\>20\\%\\.2\\ exclusion\\ of\\ the\\ aneurysm\\ sac\\ from\\ systemic\\ pressure\\ and\\ flow\\ is\\ necessary\\ to\\ prevent\\ rupture\\ and\\ thrombosis\\.\\ \ \(0\)\
\-\ in\\ a\\ study\\ of\\ 35\\ paas\\ conducted\\ by\\ morrisey\\ et\\ al\\.\\,\\ 34\\ were\\ successfully\\ excluded\\ by\\ means\\ of\\ an\\ endovascular\\ stent\\-graft\\.\\ this\\ included\\ three\\ patients\\ with\\ acute\\ rupture\\.\\ eighteen\\ of\\ these\\ patients\\ had\\ iliac\\ artery\\ paas\\.3\\ van\\ herwaarden\\ et\\ al\\.\\ reported\\ a\\ series\\ of\\ 14\\ patients\\ with\\ paas\\,\\ 8\\ of\\ which\\ involved\\ the\\ iliac\\ arteries\\.\\ at\\ a\\ median\\ followup\\ of\\ 12\\ months\\,\\ all\\ aneurysm\\ sacs\\ remained\\ excluded\\.4\\ \ \(0\)\
\-\ most\\ recently\\,\\ tielliu\\ et\\ al\\.\\ performed\\ a\\ prospective\\ study\\ where\\ 35\\ patients\\ with\\ 40\\ iliac\\ artery\\ aneurysms\\ were\\ treated\\ with\\ stent\\-grafts\\.\\ there\\ were\\ 26\\ paas\\ in\\ this\\ series\\.\\ only\\ one\\ aneurysm\\ was\\ not\\ effectively\\ excluded\\,\\ but\\ this\\ was\\ corrected\\ on\\ the\\ first\\ postoperative\\ day\\ by\\ embolization\\ of\\ the\\ native\\ external\\ iliac\\ vessel\\ \\(type\\ ii\\ endoleak\\)\\.\\ one\\-month\\ followup\\ revealed\\ only\\ 2\\ complications\\:\\ one\\ graft\\ occlusion\\,\\ and\\ one\\ type\\ i\\ endoleak\\.1\\ \ \(0\)\
\-\ endovascular\\ therapy\\ offers\\ multiple\\ advantages\\ over\\ an\\ open\\ repair\\.\\ first\\,\\ because\\ there\\ is\\ no\\ dissection\\ through\\ scarred\\ fields\\,\\ there\\ is\\ less\\ risk\\ of\\ iatrogenic\\ injury\\ to\\ vessels\\ and\\ organs\\ and\\ less\\ blood\\ loss\\.\\ second\\,\\ the\\ procedure\\ can\\ be\\ performed\\ under\\ conscious\\ sedation\\.\\ this\\ is\\ particularly\\ beneficial\\ in\\ the\\ typical\\ patient\\ with\\ tenuous\\ cardiovascular\\ status\\.\\ third\\,\\ small\\ groin\\ incisions\\ pose\\ less\\ risk\\ for\\ infection\\ and\\ problems\\ with\\ healing\\ when\\ compared\\ to\\ large\\ midline\\ incisions\\.3\\ \ \(0\)\
\-\ however\\,\\ the\\ technique\\ is\\ not\\ without\\ problems\\.\\ the\\ hypogastric\\ artery\\ may\\ be\\ intentionally\\ sacrificed\\,\\ or\\ inadvertently\\ occluded\\,\\ leading\\ to\\ pelvic\\ ischemia\\ and\\ symptoms\\ such\\ as\\ gluteal\\ claudication\\.\\ this\\ is\\ typically\\ only\\ a\\ concern\\ when\\ the\\ contralateral\\ hypogastric\\ artery\\ is\\ occluded\\ already\\.\\ migration\\ of\\ the\\ device\\ or\\ collateral\\ flow\\ can\\ result\\ in\\ an\\ endoleak\\.\\ also\\,\\ the\\ inherent\\ risks\\ of\\ angiography\\ are\\ not\\ to\\ be\\ ignored\\.\\ nevertheless\\,\\ in\\ the\\ case\\ of\\ an\\ uncomplicated\\ iliac\\ artery\\ paa\\,\\ it\\ can\\ be\\ argued\\ that\\ the\\ benefits\\ of\\ endovascular\\ stent\\-grafting\\ far\\ outweigh\\ the\\ risks\\ of\\ open\\ repair\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\-\\-\\:\\ 0\\.23504007758950565\ \(0\)\
\-\ paas\\:\\ 0\\.05278753547285329\ \(0\)\
\-\ iliac\\:\\ 0\\.05103762314210728\ \(0\)\
\-\ aneurysm\\:\\ 0\\.05056046579406142\ \(0\)\
\-\ endovascular\\:\\ 0\\.04805193881287519\ \(0\)\
\-\ endoleak\\:\\ 0\\.03236263702784011\ \(0\)\
\-\ stent\\-grafting\\:\\ 0\\.026393767736426644\ \(0\)\
\-\ stent\\-grafts\\:\\ 0\\.026393767736426644\ \(0\)\
\-\ paa\\:\\ 0\\.026393767736426644\ \(0\)\
\-\ hypogastric\\:\\ 0\\.024318476776666327\ \(0\)\
\-\ bypass\\:\\ 0\\.023753703140794925\ \(0\)\
\-\ pseudoaneurysm\\:\\ 0\\.023254186815449607\ \(0\)\
\-\ artery\\:\\ 0\\.02285505980935508\ \(0\)\
\-\ graft\\:\\ 0\\.02269903431859103\ \(0\)\
\-\ stent\\-graft\\:\\ 0\\.02224318581690601\ \(0\)\
\-\ followup\\:\\ 0\\.01832029929149103\ \(0\)\
\-\ psa\\:\\ 0\\.0179110930536236\ \(0\)\
\-\ anastomosis\\:\\ 0\\.01773996007805489\ \(0\)\
\-\ exclusion\\:\\ 0\\.01713914961259935\ \(0\)\
\-\ occluded\\:\\ 0\\.01652599268850949\ \(0\)\
\-\ risks\\:\\ 0\\.01652599268850949\ \(0\)\
\-\ rupture\\:\\ 0\\.016294008764037766\ \(0\)\
\-\ et\\:\\ 0\\.015706879177195876\ \(0\)\
\-\ excluded\\:\\ 0\\.01384989126329363\ \(0\)\
\-\ patients\\:\\ 0\\.013242961672850455\ \(0\)\
\-\ wdwnwm\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ analyis\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ end\\-to\\-side\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ aortic\\-right\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ fluency\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ tempe\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ az\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ anastamotic\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ aorta\\-right\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ 7404\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ 2006\\-10\\-24\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ 19\\:24\\:49\\-04\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ 2006\\-10\\-29\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ 15\\:57\\:51\\.572611\\-05\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ para\\-anastomotic\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ bifurcated\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ aorto\\-iliac\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ graft\\.1\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ morrisey\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ paas\\.3\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ herwaarden\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ excluded\\.4\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ tielliu\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ one\\-month\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ endoleak\\.1\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ incisions\\.3\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ sacrificed\\:\\ 0\\.013196883868213322\ \(0\)\
\-\ less\\:\\ 0\\.012996736546359352\ \(0\)\
\-\ angiography\\:\\ 0\\.012855478583585205\ \(0\)\
\-\ series\\:\\ 0\\.012728054588319349\ \(0\)\
\-\ sac\\:\\ 0\\.012403262244025725\ \(0\)\
\-\ an\\:\\ 0\\.012382715643702257\ \(0\)\
\-\ bard\\:\\ 0\\.012159238388333164\ \(0\)\
\-\ cumulative\\:\\ 0\\.012159238388333164\ \(0\)\
\-\ scarred\\:\\ 0\\.012159238388333164\ \(0\)\
\-\ tenuous\\:\\ 0\\.012159238388333164\ \(0\)\
\-\ incisions\\:\\ 0\\.012159238388333164\ \(0\)\
\-\ argued\\:\\ 0\\.012159238388333164\ \(0\)\
\-\ problems\\:\\ 0\\.011843431196421636\ \(0\)\
\-\ 35\\:\\ 0\\.011774600303533316\ \(0\)\
\-\ were\\:\\ 0\\.011618481058023482\ \(0\)\
\-\ escalating\\:\\ 0\\.011552254693560462\ \(0\)\
\-\ applications\\:\\ 0\\.011552254693560462\ \(0\)\
\-\ constantly\\:\\ 0\\.011552254693560462\ \(0\)\
\-\ eighteen\\:\\ 0\\.011552254693560462\ \(0\)\
\-\ ignored\\:\\ 0\\.011552254693560462\ \(0\)\
\-\ only\\:\\ 0\\.011539273915351507\ \(0\)\
\-\ there\\:\\ 0\\.011422594818547802\ \(0\)\
\-\ open\\:\\ 0\\.011371971817819083\ \(0\)\
\-\ advocate\\:\\ 0\\.011121592908453005\ \(0\)\
\-\ conscious\\:\\ 0\\.011121592908453005\ \(0\)\
\-\ intentionally\\:\\ 0\\.011121592908453005\ \(0\)\
\-\ inadvertently\\:\\ 0\\.011121592908453005\ \(0\)\
\-\ external\\:\\ 0\\.010879445729564112\ \(0\)\
\-\ al\\:\\ 0\\.010845992733761342\ \(0\)\
\-\ sacs\\:\\ 0\\.010787545675946704\ \(0\)\
\-\ pose\\:\\ 0\\.010787545675946704\ \(0\)\
\-\ inherent\\:\\ 0\\.010787545675946704\ \(0\)\
\-\ outweigh\\:\\ 0\\.010787545675946704\ \(0\)\
\-\ procedure\\:\\ 0\\.01071579778783398\ \(0\)\
\-\ offers\\:\\ 0\\.010514609213680304\ \(0\)\
\-\ advantages\\:\\ 0\\.010514609213680304\ \(0\)\
\-\ one\\:\\ 0\\.010399991242413071\ \(0\)\
\-\ placement\\:\\ 0\\.010384463752242603\ \(0\)\
\-\ acr\\:\\ 0\\.010283844722920935\ \(0\)\
\-\ 9\\.4\\:\\ 0\\.010283844722920935\ \(0\)\
\-\ native\\:\\ 0\\.010283844722920935\ \(0\)\
\-\ repair\\:\\ 0\\.0102451822683058\ \(0\)\
\-\ \\:\\:\\ 0\\.010152169005904177\ \(0\)\
\-\ complications\\:\\ 0\\.010138241901233705\ \(0\)\
\-\ effectively\\:\\ 0\\.010083947428572848\ \(0\)\
\-\ claudication\\:\\ 0\\.010083947428572848\ \(0\)\
\-\ anastomotic\\:\\ 0\\.009907625518907602\ \(0\)\
\-\ exquisite\\:\\ 0\\.009749900196066546\ \(0\)\
\-\ arteriogram\\:\\ 0\\.009749900196066546\ \(0\)\
\-\ come\\:\\ 0\\.009749900196066546\ \(0\)\
\-\ gluteal\\:\\ 0\\.009749900196066546\ \(0\)\
\-\ occlusive\\:\\ 0\\.009607220286179833\ \(0\)\
\-\ evolving\\:\\ 0\\.009607220286179833\ \(0\)\
\-\ nevertheless\\:\\ 0\\.009607220286179833\ \(0\)\
\-\ so\\-called\\:\\ 0\\.009476963733800147\ \(0\)\
\-\ \\.2\\:\\ 0\\.009476963733800147\ \(0\)\
\-\ sedation\\:\\ 0\\.009476963733800147\ \(0\)\
\-\ \\,\\:\\ 0\\.00932085554924792\ \(0\)\
\-\ risk\\:\\ 0\\.009267085770536188\ \(0\)\
\-\ beneficial\\:\\ 0\\.009246199243040779\ \(0\)\
\-\ 20\\:\\ 0\\.009199147413643761\ \(0\)\
\-\ al\\.\\:\\ 0\\.009142916501293844\ \(0\)\
\-\ van\\:\\ 0\\.009142916501293844\ \(0\)\
\-\ quadrant\\:\\ 0\\.009004119562832499\ \(0\)\
\-\ colectomy\\:\\ 0\\.0089555465268118\ \(0\)\
\-\ created\\:\\ 0\\.008869980039027446\ \(0\)\
\-\ corrected\\:\\ 0\\.008869980039027446\ \(0\)\
\-\ can\\:\\ 0\\.008704591403304204\ \(0\)\
\-\ covered\\:\\ 0\\.008639215548268077\ \(0\)\
\-\ type\\:\\ 0\\.008624623438164402\ \(0\)\
\-\ first\\:\\ 0\\.008585279744867821\ \(0\)\
\-\ completion\\:\\ 0\\.008569574806299675\ \(0\)\
\-\ modified\\:\\ 0\\.008569574806299675\ \(0\)\
\-\ flow\\:\\ 0\\.008455251128318911\ \(0\)\
\-\ conducted\\:\\ 0\\.008439318253919989\ \(0\)\
\-\ prospective\\:\\ 0\\.008439318253919989\ \(0\)\
\-\ benefits\\:\\ 0\\.008439318253919989\ \(0\)\
\-\ study\\:\\ 0\\.008418057954670537\ \(0\)\
\-\ revealed\\:\\ 0\\.008210999670257764\ \(0\)\
\-\ means\\:\\ 0\\.008105271021413687\ \(0\)\
\-\ 69\\:\\ 0\\.008056184460301426\ \(0\)\
\-\ prompted\\:\\ 0\\.007962591111526973\ \(0\)\
\-\ be\\:\\ 0\\.007890758822418738\ \(0\)\
\-\ attention\\:\\ 0\\.007874506530654319\ \(0\)\
\-\ days\\:\\ 0\\.007841539808898138\ \(0\)\
\-\ established\\:\\ 0\\.007832334559147289\ \(0\)\
\-\ iatrogenic\\:\\ 0\\.0077913181307219664\ \(0\)\
\-\ successfully\\:\\ 0\\.00775139560514987\ \(0\)\
\-\ device\\:\\ 0\\.007712510146462354\ \(0\)\
\-\ obstructing\\:\\ 0\\.00767460923630623\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.00767460923630623\ \(0\)\
\-\ aneurysms\\:\\ 0\\.00767460923630623\ \(0\)\
\-\ already\\:\\ 0\\.007601570068387919\ \(0\)\
\-\ is\\:\\ 0\\.00757577396027325\ \(0\)\
\-\ migration\\:\\ 0\\.007566344772863677\ \(0\)\
\-\ index\\:\\ 0\\.007433189853677306\ \(0\)\
\-\ postoperative\\:\\ 0\\.007433189853677306\ \(0\)\
\-\ groin\\:\\ 0\\.007433189853677306\ \(0\)\
\-\ extended\\:\\ 0\\.007401672774039832\ \(0\)\
\-\ median\\:\\ 0\\.007401672774039832\ \(0\)\
\-\ was\\:\\ 0\\.007397286842916817\ \(0\)\
\-\ technique\\:\\ 0\\.00737080557762855\ \(0\)\
\-\ organs\\:\\ 0\\.007340562003799928\ \(0\)\
\-\ when\\:\\ 0\\.007327339034778461\ \(0\)\
\-\ excellent\\:\\ 0\\.007310917352158941\ \(0\)\
\-\ far\\:\\ 0\\.007225350864374587\ \(0\)\
\-\ stent\\:\\ 0\\.007197882093913215\ \(0\)\
\-\ uncomplicated\\:\\ 0\\.007197882093913215\ \(0\)\
\-\ this\\:\\ 0\\.007194140818219559\ \(0\)\
\-\ cardiovascular\\:\\ 0\\.007170908283280463\ \(0\)\
\-\ he\\:\\ 0\\.007138285455188681\ \(0\)\
\-\ performed\\:\\ 0\\.007133468057566824\ \(0\)\
\-\ nad\\:\\ 0\\.007092785898294579\ \(0\)\
\-\ contralateral\\:\\ 0\\.00706762554153353\ \(0\)\
\-\ remained\\:\\ 0\\.006971010988932375\ \(0\)\
\-\ fields\\:\\ 0\\.006971010988932375\ \(0\)\
\-\ distal\\:\\ 0\\.006955923919000081\ \(0\)\
\-\ brought\\:\\ 0\\.006947801128848594\ \(0\)\
\-\ at\\:\\ 0\\.0069327134900097785\ \(0\)\
\-\ literature\\:\\ 0\\.006880255567051485\ \(0\)\
\-\ ascending\\:\\ 0\\.0068584010769000585\ \(0\)\
\-\ exclude\\:\\ 0\\.006794689079267131\ \(0\)\
\-\ topic\\:\\ 0\\.006794689079267131\ \(0\)\
\-\ evidence\\:\\ 0\\.006707911926248138\ \(0\)\
\-\ collateral\\:\\ 0\\.006694181140887447\ \(0\)\
\-\ these\\:\\ 0\\.006658217640592336\ \(0\)\
\-\ particularly\\:\\ 0\\.006599998767518331\ \(0\)\
\-\ healing\\:\\ 0\\.006599998767518331\ \(0\)\
\-\ patient\\:\\ 0\\.006411616249374161\ \(0\)\
\-\ by\\:\\ 0\\.0063901387870278804\ \(0\)\
\-\ occlusion\\:\\ 0\\.00637970289276341\ \(0\)\
\-\ symptoms\\:\\ 0\\.0063762199907129915\ \(0\)\
\-\ concern\\:\\ 0\\.0063640272941596744\ \(0\)\
\-\ prevent\\:\\ 0\\.006348514139914844\ \(0\)\
\-\ 34\\:\\ 0\\.006348514139914844\ \(0\)\
\-\ dissection\\:\\ 0\\.006288020819049759\ \(0\)\
\-\ systemic\\:\\ 0\\.0061199559958894575\ \(0\)\
\-\ leading\\:\\ 0\\.0061199559958894575\ \(0\)\
\-\ become\\:\\ 0\\.0060936920592863\ \(0\)\
\-\ vessel\\:\\ 0\\.0060936920592863\ \(0\)\
\-\ discussion\\:\\ 0\\.00599301507274563\ \(0\)\
\-\ 3\\:\\ 0\\.005990944690738143\ \(0\)\
\-\ recently\\:\\ 0\\.00596886929141347\ \(0\)\
\-\ embolization\\:\\ 0\\.005956940893735061\ \(0\)\
\-\ ischemia\\:\\ 0\\.005945106792676508\ \(0\)\
\-\ 26\\:\\ 0\\.005921715598210818\ \(0\)\
\-\ included\\:\\ 0\\.005898684282582855\ \(0\)\
\-\ incidence\\:\\ 0\\.005864788359304771\ \(0\)\
\-\ lower\\:\\ 0\\.005754078051987613\ \(0\)\
\-\ to\\:\\ 0\\.005753911640698917\ \(0\)\
\-\ report\\:\\ 0\\.005726176402975691\ \(0\)\
\-\ necessary\\:\\ 0\\.005666288177506082\ \(0\)\
\-\ 14\\:\\ 0\\.005637219186702038\ \(0\)\
\-\ case\\:\\ 0\\.005597318661279254\ \(0\)\
\-\ under\\:\\ 0\\.005589991106260532\ \(0\)\
\-\ not\\:\\ 0\\.005545592837164381\ \(0\)\
\-\ near\\:\\ 0\\.005535216484355903\ \(0\)\
\-\ had\\:\\ 0\\.005520508440840444\ \(0\)\
\-\ ii\\:\\ 0\\.005517394774017103\ \(0\)\
\-\ intermittent\\:\\ 0\\.005491053813103362\ \(0\)\
\-\ thrombosis\\:\\ 0\\.005491053813103362\ \(0\)\
\-\ \\-\\:\\ 0\\.005484216942240609\ \(0\)\
\-\ but\\:\\ 0\\.005456596709681251\ \(0\)\
\-\ compared\\:\\ 0\\.005414702683683642\ \(0\)\
\-\ 40\\:\\ 0\\.00538197993845535\ \(0\)\
\-\ the\\:\\ 0\\.005380960183075256\ \(0\)\
\-\ s\\/p\\:\\ 0\\.005365882944778311\ \(0\)\
\-\ involved\\:\\ 0\\.005365882944778311\ \(0\)\
\-\ a\\:\\ 0\\.005343410503544029\ \(0\)\
\-\ arteries\\:\\ 0\\.005295514617868235\ \(0\)\
\-\ i\\:\\ 0\\.005287896250342081\ \(0\)\
\-\ pelvic\\:\\ 0\\.005250375339169601\ \(0\)\
\-\ 12\\:\\ 0\\.005235626392398626\ \(0\)\
\-\ where\\:\\ 0\\.005221021340085206\ \(0\)\
\-\ treatment\\:\\ 0\\.00517849389102062\ \(0\)\
\-\ aortic\\:\\ 0\\.005178042139662404\ \(0\)\
\-\ no\\:\\ 0\\.005152360183855102\ \(0\)\
\-\ vessels\\:\\ 0\\.005150059904614271\ \(0\)\
\-\ typical\\:\\ 0\\.005129411218787422\ \(0\)\
\-\ third\\:\\ 0\\.005129411218787422\ \(0\)\
\-\ 15\\:\\ 0\\.005102315348063442\ \(0\)\
\-\ in\\:\\ 0\\.005046673414853353\ \(0\)\
\-\ also\\:\\ 0\\.005043771238533387\ \(0\)\
\-\ worsening\\:\\ 0\\.005036646662276644\ \(0\)\
\-\ colon\\:\\ 0\\.005023851661410688\ \(0\)\
\-\ pressure\\:\\ 0\\.005023851661410688\ \(0\)\
\-\ midline\\:\\ 0\\.0049492965379319175\ \(0\)\
\-\ second\\:\\ 0\\.004913366669519428\ \(0\)\
\-\ result\\:\\ 0\\.004907461312796351\ \(0\)\
\-\ femoral\\:\\ 0\\.0048667634979697675\ \(0\)\
\-\ commonly\\:\\ 0\\.004827142879424613\ \(0\)\
\-\ has\\:\\ 0\\.004804490929623587\ \(0\)\
\-\ occur\\:\\ 0\\.004799471001169968\ \(0\)\
\-\ 8\\:\\ 0\\.004783110117139743\ \(0\)\
\-\ which\\:\\ 0\\.004775881997732182\ \(0\)\
\-\ laboratory\\:\\ 0\\.004714209185410279\ \(0\)\
\-\ mm\\:\\ 0\\.004703884965261984\ \(0\)\
\-\ year\\-old\\:\\ 0\\.0046987494336799655\ \(0\)\
\-\ reported\\:\\ 0\\.004663285704454808\ \(0\)\
\-\ later\\:\\ 0\\.004618890181127132\ \(0\)\
\-\ status\\:\\ 0\\.004566358265241996\ \(0\)\
\-\ typically\\:\\ 0\\.0045156074393801985\ \(0\)\
\-\ because\\:\\ 0\\.004475326821236599\ \(0\)\
\-\ inflammatory\\:\\ 0\\.004436101712862311\ \(0\)\
\-\ underwent\\:\\ 0\\.004389515023170987\ \(0\)\
\-\ for\\:\\ 0\\.004365917057740809\ \(0\)\
\-\ \\(\\:\\ 0\\.004325519318825513\ \(0\)\
\-\ although\\:\\ 0\\.004320253414036832\ \(0\)\
\-\ 10\\:\\ 0\\.004312311719082201\ \(0\)\
\-\ three\\:\\ 0\\.004312311719082201\ \(0\)\
\-\ \\)\\:\\ 0\\.004272680791097635\ \(0\)\
\-\ palpation\\:\\ 0\\.004269369880760557\ \(0\)\
\-\ \\>\\:\\ 0\\.004250250770461923\ \(0\)\
\-\ unremarkable\\:\\ 0\\.004235129369284522\ \(0\)\
\-\ x\\:\\ 0\\.004220159184651912\ \(0\)\
\-\ vascular\\:\\ 0\\.004194316269346851\ \(0\)\
\-\ injury\\:\\ 0\\.004078156499833533\ \(0\)\
\-\ day\\:\\ 0\\.004061317109809775\ \(0\)\
\-\ right\\:\\ 0\\.004049244202591691\ \(0\)\
\-\ while\\:\\ 0\\.004024924011754961\ \(0\)\
\-\ such\\:\\ 0\\.003999001182396485\ \(0\)\
\-\ medical\\:\\ 0\\.003936092515068869\ \(0\)\
\-\ tenderness\\:\\ 0\\.003890587309703044\ \(0\)\
\-\ as\\:\\ 0\\.0038699925326171492\ \(0\)\
\-\ of\\:\\ 0\\.0038369515232870442\ \(0\)\
\-\ treated\\:\\ 0\\.00382911801808961\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.003823393322822539\ \(0\)\
\-\ from\\:\\ 0\\.0037917236920784803\ \(0\)\
\-\ years\\:\\ 0\\.0037563520015246746\ \(0\)\
\-\ infection\\:\\ 0\\.0037185876857377355\ \(0\)\
\-\ loss\\:\\ 0\\.0037132697192641313\ \(0\)\
\-\ s\\:\\ 0\\.0036688138729260287\ \(0\)\
\-\ through\\:\\ 0\\.003633169189252798\ \(0\)\
\-\ carcinoma\\:\\ 0\\.003625640224574651\ \(0\)\
\-\ all\\:\\ 0\\.0036181489362743877\ \(0\)\
\-\ 4\\:\\ 0\\.0035643291993698286\ \(0\)\
\-\ however\\:\\ 0\\.0035619282269417226\ \(0\)\
\-\ months\\:\\ 0\\.0034939240938474062\ \(0\)\
\-\ blood\\:\\ 0\\.00349163334207979\ \(0\)\
\-\ are\\:\\ 0\\.0034876463249389274\ \(0\)\
\-\ presented\\:\\ 0\\.0034870623278778585\ \(0\)\
\-\ cm\\:\\ 0\\.0034310720326601587\ \(0\)\
\-\ therapy\\:\\ 0\\.0034201209524560077\ \(0\)\
\-\ over\\:\\ 0\\.003256949985239465\ \(0\)\
\-\ acute\\:\\ 0\\.003158501989680382\ \(0\)\
\-\ surgery\\:\\ 0\\.00310628602449143\ \(0\)\
\-\ without\\:\\ 0\\.0030119957580211983\ \(0\)\
\-\ or\\:\\ 0\\.002998571104681759\ \(0\)\
\-\ \\%\\:\\ 0\\.0029840135229730657\ \(0\)\
\-\ most\\:\\ 0\\.002953346020551012\ \(0\)\
\-\ other\\:\\ 0\\.002948560701650372\ \(0\)\
\-\ small\\:\\ 0\\.002946968988594489\ \(0\)\
\-\ it\\:\\ 0\\.002875521533732061\ \(0\)\
\-\ may\\:\\ 0\\.0028058807917636587\ \(0\)\
\-\ large\\:\\ 0\\.002797219209327964\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0027943431162472847\ \(0\)\
\-\ 2\\:\\ 0\\.0027546474498660873\ \(0\)\
\-\ multiple\\:\\ 0\\.0026943203644899235\ \(0\)\
\-\ and\\:\\ 0\\.0024252710353143206\ \(0\)\
\-\ male\\:\\ 0\\.002313181942945319\ \(0\)\
\-\ that\\:\\ 0\\.002209551988860514\ \(0\)\
\-\ disease\\:\\ 0\\.002090924462897761\ \(0\)\
\-\ ct\\:\\ 0\\.001789376726634795\ \(0\)\
\-\ \\.\\:\\ 0\\.0017537195976233939\ \(0\)\
\-\ with\\:\\ 0\\.0015764035700733647\ \(0\)\
\-\ pain\\:\\ 0\\.0015622876759442137\ \(0\)\
\-\ left\\:\\ 0\\.0014312953132828066\ \(0\)\
\-\ year\\:\\ 0\\.0014312953132828066\ \(0\)\
\-\ on\\:\\ 0\\.0010836691801877666\ \(0\)\
